Changing the Face of Cardiovascular Trial Participation: Moving Beyond Middle-Aged White Guys -н David D. Waters, MD

Бүрэн текст авах

Atorvastatin Has a Dose‐Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double‐Blind Randomized Controlled Trials -н Liffert Vogt, Sripal Bangalore, Rana Fayyad, Shari Melamed, G. Kees Hovingh, David A. DeMicco, David D. Waters

Бүрэн текст авах

The association between lipid levels and leukocyte count: A cross-sectional and longitudinal analysis of three large cohorts -н Sonia Sawant, Bradley Tucker, Praween Senanayake, David D. Waters, Sanjay Patel, Kerry-Anne Rye, Kwok Leung Ong, Blake J. Cochran

Бүрэн текст авах

Relationship of High‐Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin -н Kwok Leung Ong, David D. Waters, Rana Fayyad, Liffert Vogt, Shari Melamed, David A. DeMicco, Kerry‐Anne Rye, Philip J. Barter

Бүрэн текст авах

Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers. -н Benoit J Arsenault, Philip Barter, David A DeMicco, Weihang Bao, Gregory M Preston, John C LaRosa, Scott M Grundy, Prakash Deedwania, Heiner Greten, Nanette K Wenger, James Shepherd, David D Waters, John J P Kastelein, Treating to New Targets (TNT) Investigators

Бүрэн текст авах